Alteplase Impedes Progression of Post-Stroke Ischemic Brain Lesions


In this randomized controlled trial of IV alteplase for ischemic stroke, researchers evaluated CT or brain MRI scans before treatment and 24 to 48 hours after treatment for acute lesion visibility, extent, and swelling.